fluspirilene has been researched along with Somatoform Disorders in 3 studies
Fluspirilene: A long-acting injectable antipsychotic agent used for chronic schizophrenia.
Somatoform Disorders: Disorders having the presence of physical symptoms that suggest a general medical condition but that are not fully explained by another medical condition, by the direct effects of a substance, or by another mental disorder. The MEDICALLY UNEXPLAINED SYMPTOMS must cause clinically significant distress or impairment in social, occupational, or other areas of functioning. In contrast to FACTITIOUS DISORDERS and MALINGERING, the physical symptoms are not under voluntary control. (APA, DSM-V)
| Excerpt | Relevance | Reference |
|---|---|---|
| "A group of 82 nonselected patients with the leading symptom "anxiety" as part of psychoreactive disturbances was included in a study comparing the effectiveness of fluspirilene and bromazepam." | 9.05 | [Leading symptom of anxiety and tension and its concomitant somatic manifestations. A multicenter trial of fluspirilene versus bromazepam]. ( Thilmann, J, 1983) |
| "A group of 82 nonselected patients with the leading symptom "anxiety" as part of psychoreactive disturbances was included in a study comparing the effectiveness of fluspirilene and bromazepam." | 5.05 | [Leading symptom of anxiety and tension and its concomitant somatic manifestations. A multicenter trial of fluspirilene versus bromazepam]. ( Thilmann, J, 1983) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Thilmann, J | 1 |
| Schwab, H | 1 |
| Pein, R | 1 |
| Wittenbeck, K | 1 |
| Hassel, P | 1 |
2 trials available for fluspirilene and Somatoform Disorders
| Article | Year |
|---|---|
[Leading symptom of anxiety and tension and its concomitant somatic manifestations. A multicenter trial of fluspirilene versus bromazepam].
Topics: Adult; Aged; Anti-Anxiety Agents; Anxiety; Bromazepam; Clinical Trials as Topic; Female; Fluspirilen | 1983 |
Experimental comparison of low doses of 1.5 mg fluspirilene and bromazepam in out-patients with psychovegetative disturbances.
Topics: Adult; Anti-Anxiety Agents; Anxiety Disorders; Arousal; Attention; Bromazepam; Dose-Response Relatio | 1985 |
1 other study available for fluspirilene and Somatoform Disorders
| Article | Year |
|---|---|
[Psychovegetative disorders in gynecology. Treatment with Imap 1.5 mg].
Topics: Adolescent; Adult; Aged; Female; Fluspirilene; Genital Diseases, Female; Humans; Middle Aged; Psycho | 1982 |